Showing results (191-200 of 810) with videos related to
Sort By:
Pageof 81
Hepatology (Baltimore, Md.)|May 21, 2022
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver diseaseLukas Hartl, Katharina Haslinger, Martin Angerer, et al.Journal of Hepatology|May 25, 2025
Enteronephrohepatic circulation of bile acids and therapeutic potential of systemic bile acid transporter inhibitorsAhmed Ghallab, Mattias Mandorfer, Guido Stirnimann, et al.Wiener Klinische Wochenschrift|September 4, 2016
Indications for liver transplantation in adults : Recommendations of the Austrian Society for Gastroenterology and Hepatology (ÖGGH) in cooperation with the Austrian Society for Transplantation, Transfusion and Genetics (ATX)Ivo Graziadei, Heinz Zoller, Peter Fickert, et al.Wiener Klinische Wochenschrift|November 12, 2022
The impact of COVID-19 on liver transplantation programs in AustriaLukas Hartl, Elisabeth Tatscher, Melanie Weiss, et al.Gastroenterology|October 18, 2011
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injuryTarek Moustafa, Peter Fickert, Christoph Magnes, et al.Journal of Clinical Pathology|May 10, 2012
Is there a rationale to record lymphatic invasion in node-positive colorectal cancer?Johannes Betge, Nora I Schneider, Marion J Pollheimer, et al.Histopathology|December 25, 2016
Anal verrucous carcinoma is not related to infection with human papillomaviruses and should be distinguished from giant condyloma (Buschke-Löwenstein tumour)Nina Zidar, Cord Langner, Katarina Odar, et al.BMC Nephrology|March 16, 2019
The conundrum of postpartum thrombotic Microangiopathy: case report and considerations for managementKatharina Artinger, Gerald Hackl, Gernot Schilcher, et al.Current Opinion in Critical Care|March 2, 2013
The liver in sepsis: patterns of response and injuryMichael Bauer, Adrian T Press, Michael TraunerJournal of Hepatology|October 22, 2022
Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†Frederik Nevens, Michael Trauner, Michael P MannsPageof 81